REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.69 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,043,770 | -98.4% | 91,000 | -96.5% | 0.00% | -100.0% |
| Q2 2023 | $65,711,417 | +3.1% | 2,596,263 | +31.2% | 0.03% | 0.0% |
| Q1 2023 | $63,729,321 | +3990.4% | 1,978,557 | +2244.3% | 0.03% | +2600.0% |
| Q4 2022 | $1,558,024 | -50.4% | 84,400 | -27.5% | 0.00% | -50.0% |
| Q3 2022 | $3,144,000 | +95.4% | 116,447 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $1,609,000 | -42.7% | 116,447 | -19.1% | 0.00% | 0.0% |
| Q1 2022 | $2,807,000 | +19.7% | 143,947 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $2,346,000 | -97.4% | 143,747 | -95.6% | 0.00% | -97.2% |
| Q3 2021 | $91,425,000 | -0.1% | 3,281,595 | +6.3% | 0.04% | -2.7% |
| Q2 2021 | $91,518,000 | -2.4% | 3,087,666 | -7.9% | 0.04% | -9.8% |
| Q1 2021 | $93,724,000 | +7.9% | 3,353,279 | +9.4% | 0.04% | 0.0% |
| Q4 2020 | $86,888,000 | +32.8% | 3,065,904 | +17.8% | 0.04% | +17.1% |
| Q3 2020 | $65,452,000 | -4.0% | 2,603,516 | -6.8% | 0.04% | -12.5% |
| Q2 2020 | $68,200,000 | +108.3% | 2,792,810 | +26.2% | 0.04% | +73.9% |
| Q1 2020 | $32,740,000 | +3.4% | 2,212,173 | +13.4% | 0.02% | +27.8% |
| Q4 2019 | $31,664,000 | +17.5% | 1,950,975 | -5.9% | 0.02% | +5.9% |
| Q3 2019 | $26,952,000 | +1.7% | 2,073,211 | +1.4% | 0.02% | +6.2% |
| Q2 2019 | $26,508,000 | -17.6% | 2,043,800 | +0.1% | 0.02% | -23.8% |
| Q1 2019 | $32,168,000 | +2.4% | 2,041,129 | +30.7% | 0.02% | -8.7% |
| Q4 2018 | $31,427,000 | -23.4% | 1,561,192 | -5.5% | 0.02% | -14.8% |
| Q3 2018 | $41,051,000 | +14.2% | 1,651,949 | +26.1% | 0.03% | +8.0% |
| Q2 2018 | $35,961,000 | +2.5% | 1,310,053 | +15.0% | 0.02% | 0.0% |
| Q1 2018 | $35,085,000 | +8.1% | 1,139,111 | +25.5% | 0.02% | +8.7% |
| Q4 2017 | $32,450,000 | +5299.3% | 907,695 | +4063.7% | 0.02% | – |
| Q3 2017 | $601,000 | -5.2% | 21,800 | -9.2% | 0.00% | – |
| Q2 2017 | $634,000 | +27.1% | 24,000 | 0.0% | 0.00% | – |
| Q1 2017 | $499,000 | -13.2% | 24,000 | -13.7% | 0.00% | – |
| Q4 2016 | $575,000 | +20.5% | 27,800 | -5.4% | 0.00% | – |
| Q3 2016 | $477,000 | -0.6% | 29,400 | -16.7% | 0.00% | – |
| Q2 2016 | $480,000 | +8.6% | 35,300 | +39.5% | 0.00% | – |
| Q1 2016 | $442,000 | -48.8% | 25,300 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $864,000 | +30.7% | 25,300 | +14.0% | 0.00% | 0.0% |
| Q3 2015 | $661,000 | +3.9% | 22,200 | +11.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +326.8% | 19,900 | +176.4% | 0.00% | – |
| Q1 2015 | $149,000 | -98.5% | 7,200 | -98.7% | 0.00% | -100.0% |
| Q4 2014 | $9,756,000 | -2.1% | 575,906 | +11.7% | 0.01% | 0.0% |
| Q3 2014 | $9,967,000 | -21.6% | 515,614 | +37.9% | 0.01% | -27.3% |
| Q2 2014 | $12,713,000 | – | 373,921 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |